Dravet Syndrome (DS) is a devastating pediatric diagnosis that also has a high fatality rate. Given that orthodox anti-seizure regimens are woefully inadequate, the need for novel, safe, and effective treatment remains urgent.
The CannaKeys Dravet Syndrome treatment algorithm is based on review and analysis of scientific literature and clinical expert opinion. Focused on aspects that can be controlled in the clinical setting, it is designed to be used as a tool for creating optimal cannabinoid-based therapeutics for Dravet Syndrome patients while managing the complexities of the endocannabinoid system.
If you are seeing this message, you are not a CannaKeys subscriber and can't download this cannabis treatment algorithm.
Learn more about our Chronic Pain Treatment Algorithm ebooks for Clinicians and Patients.
Or subscribe to CannaKeys.com to access all of our research dashboards and treatment algorithms.
Evidence-based Guidelines for Cannabis Therapeutics
We offer a systematic approach that physicians and healthcare professionals can use to make evidence-based decisions when prescribing cannabinoids to treat dravet syndrome. Factors that can make a significant difference in optimizing patient outcomes include the choice of a primary cannabinoid, specific dosing protocols, and the form of administration.
Screening Process
Includes risk assessment, possible contraindications, and potential cannabinoid-to-pharmaceutical drug interactions.
Cannabinoid Treatment Plan
Dosing protocol includes starting dose, maximum daily dose, and titration rates for the primary cannabinoid to reduce the occurrence, severity, and lengths of seizures.
